Medicare Enrolled

Dr. Vipul Desai, MD

Infectious Disease · The Woodlands, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1111 MEDICAL PLAZA DRIVE, The Woodlands, TX 77380
2814441303
In practice since 2008 (17 years)
NPI: 1891960969 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Desai

Dr. Vipul Desai is an infectious disease in The Woodlands, TX, with 17 years in practice. Based on federal Medicare data, Dr. Desai performed 291,844 Medicare services across 835 unique beneficiaries.

Between the years covered by Open Payments, Dr. Desai received a total of $113,140 from 51 pharmaceutical and/or device companies across 1494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 1% volume in TX$ $113,140 industry payments

Medicare Practice Summary

Medicare Utilization ↗
291,844
Medicare services
Top 1% in TX for infectious disease
835
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,167 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Daptomycin antibiotic injection214,177$0$0
Injection, omadacycline, 1 mg38,801$3$6
Injection, dalbavancin, 5 mg24,700$11$36
Injection, meropenem, 100 mg6,089$0$3
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less2,207$47$132
Ceftriaxone antibiotic injection1,887$0$3
Injection, ertapenem sodium, 500 mg1,517$10$150
Office visit, established patient (30-39 min)657$92$280
Anti-nausea injection (ondansetron/Zofran)566$0$1
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less324$22$65
Office visit, established patient, complex (40-54 min)290$132$387
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion219$15$39
Injection of additional new drug or substance into vein171$11$44
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour128$15$42
New patient office visit, complex (60-74 min)61$164$535
Removal of tissue from wound, 20.0 sq cm or less30$74$125
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional20$17$58
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
98.7% medium
0.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$113,140
Total received (2018-2024)
Avg $16,163/year across 7 years
Top 5% in TX for infectious disease
51
Companies
1,494
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$87,509 (77.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,632 (22.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,811
2023
$8,984
2022
$10,243
2021
$14,091
2020
$6,065
2019
$42,118
2018
$17,827

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Melinta Therapeutics, Inc.
$41,698
Cumberland Pharmaceuticals, Inc.
$15,322
Paratek Pharmaceuticals, Inc.
$13,043
Allergan Inc.
$7,468
Ferring Pharmaceuticals Inc.
$5,387
Gilead Sciences, Inc.
$4,740
CIPLA USA INC.
$4,541
TETRAPHASE PHARMACEUTICALS, INC.
$4,396
ViiV Healthcare Company
$2,872
Insmed, Inc.
$1,668
Astellas Pharma US Inc
$1,395
Allergan, Inc.
$1,361
Smith+Nephew, Inc.
$1,057
AbbVie Inc.
$1,037
ABBVIE INC.
$968
Merck Sharp & Dohme Corporation
$945
Shionogi Inc
$746
Melinta Therapeutics, LLC
$617
Merck Sharp & Dohme LLC
$598
La Jolla Pharmaceutical Company
$499
GRT US Holding, Inc.
$416
Osiris Therapeutics Inc.
$380
Janssen Biotech, Inc.
$245
Theravance Biopharma, Inc.
$238
EMD Serono, Inc.
$200
PFIZER INC.
$136
Theratechnologies Inc.
$133
MAYNE PHARMA INC.
$104
SANOFI-AVENTIS U.S. LLC
$101
Endo Pharmaceuticals Inc.
$97
AIMMUNE THERAPEUTICS, INC.
$75
Janssen Products, LP
$70
ORGANOGENESIS INC.
$69
Abbott Laboratories
$67
Dynavax Technologies Corporation
$49
Vyera Pharmaceuticals, LLC
$43
Octapharma USA, Inc.
$41
Napo Pharmaceuticals Inc
$41
Imbed Biosciences Inc.
$36
KCI USA, Inc
$31
PORTOLA PHARMACEUTICALS, INC.
$29
Mayne Pharma Inc.
$28
Tactile Systems Technology Inc
$23
TerSera Therapeutics LLC
$22
Mylan Pharmaceuticals Inc.
$20
ConvaTec Inc.
$17
CSL Behring
$16
ETS Wound Care LLC
$15
Organogenesis Inc.
$15
Nabriva Therapeutics, plc
$14
Seqirus USA Inc
$11
Top 3 companies account for 61.9% of total payments
Associated products mentioned in payments ›
AMBISOME · APRETUDE · AQUACEL AG+ · AVYCAZ · Arikayce · BEVYXXA · Baxdela · Biktarvy · CABENUVA · COLLAGENASE SANTYL · CRESEMBA · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · Daraprim Tablet 25mg · EGRIFTA · FLEXITOUCH · Fetroja · Fluad · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix CORE · Grafix PL PRIME · GrafixPL · Heplisav-B · ISENTRESS · JULUCA · Kimyrsa · LEXISCAN · MAVYRET · MIRRAGEN ADVANCED WOUND MATRIX · MYCAMINE · Mytesi · NASCOBAL · NOXAFIL · NUZYRA · Oasis · Orbactiv · PANZYGA · PICO 7 Single Use Negative Pressure Wound Therapy · PICO7 · PIFELTRO · PRALUENT · PREVNAR 20 · PREVYMIS · PREZCOBIX · PREZISTA · Privigen · Proclaim IPG · Puraply · Qutenza · Quzyttir · REBYOTA · REGRANEX · RENASYS · SEROSTIM · SILVERCEL · SNAP · SYMTUZA · Santyl · Serostim · Stravix · Symfi Lo · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · TRUMENBA · VIBATIV · VOWST · Vabomere · Veklury · Veozah · Vibativ · XERAVA · Xenleta · Xerava · ZEMDRI (PLAZOMICIN) · ZERBAXA · ZINPLAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for infectious disease in TX.

Equivalent to $39 per 100 Medicare services performed
Looking for a infectious disease in The Woodlands?
Compare infectious diseases in the The Woodlands area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
34
Per 100K population
5.2
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Desai is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 5%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Desai experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Desai performed 214,177 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $113,140 from 51 companies across 1,494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other infectious diseases in The Woodlands?
Dr. Desai's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →